Pharmaceutics Anti-Counterfeiting | Deloitte Switzerland | Life Sciences and Health Care | Insights has been added to your bookmarks.
How secure is your supply chain
Counterfeited drugs are not only an issue in developing countries but also in the western world. Tracking and detection of sources of counterfeit drugs is difficult, and more so as only a few countries are willing to share data and information to address the issue
"The World Health Organization (WHO) estimates that up to 30% of branded drugs sold in developing nations are counterfeit"
Addressing these challenges by implementing proactive and rigorous anti-counterfeiting measures must therefore now be considered one of the first and most critical steps in establishing a secure supply chain strategy for every pharmaceutical company.